Archive

Posts tagged under: ta-Scan

Find medical experts on the go with ta-Scan Podium

With ta-Scan Podium, our new semantic search application, MDCPartners is going mobile. ta-Scan Podium allows you to leverage the powerful search capabilities of ta-Scan’s clinical intelligence database to find Key External Experts on the go, using any tablet device.

If you are moving into a new disease area or if you are trying to identify new therapeutic experts in an existing indication, why remain limited to the endless number of databases, only available on your desktop? Whether you’re at your desk, at a meeting or a conference, you can now search, refine, save, and share any expert profile with a few simple clicks on your tablet.

Learn more about Podium in the video below and see how it can improve your work effectiveness.
Book your free demo using the following link → https://www.ta-scan.com/podiumdemo

Get your FREE Immuno-Oncology Therapy Analysis by ta-Scan

Today brings the start of the Immuno-Oncology Summit 2017 in Boston, supporting researchers in developing the next generation of immunotherapies. Immuno-oncology researchers are changing the way we treat cancer by unleashing the immune system and achieving functional cures in some cancers.

MDCPartners and its ta-Scan team contribute to this purpose by teaching how clinical planners can leverage our clinical businesses intelligence software and our data merging services to get to their answers faster. The ta-Scan team created a useful analysis on oncolytic virus therapies in clinical trials. We thought today would be a good occasion to share this report with you.

>>> Click here to download the analysis <<<

BIG Data: How Pharma Can Use it to its Advantage

In this European Pharmaceutical Manufacturer Magazine opinion article, MDCPartners’ founder and CEO, Mireille De Cré, explains how pharma R&D can make the most of the big data revolution.

The big data hype train has been gaining momentum for a number of years and its rise has been well documented. However, pharma companies are still perplexed by the scope of what big data can do, and why, how and where they should use big data tools to their advantage.

With focus moving away from sheer volume of data and inherent variability and complexity of large unstructured datasets towards user-friendly analytic tools that can help businesses plan for the future, now is the time for big, small and medium size pharma to seize the ‘big data’ opportunity.

What is clear is that big data is here to stay and will continue to have a growing influence in terms of its impact to business decision making across a number of sectors. Some of those in pharma are firmly grasping the opportunity that analytics-based decision making can bring… And those that aren’t will need to catch up before they lose out.

Read more in the European Pharmaceutical Manufacturer Magazine article: http://www.epmmagazine.com/opinion/big-data/

Join MDCPartners at Clinical Trial Innovation Summit 2017

CHI’s 6th Annual Clinical Trial Innovation Summit brings together more than 250 leaders from across pharma, biotech and academia to share case studies and best practices on effective clinical trial management and vendor oversight. Of course MDCPartners’ ta-Scan team will be there too. The summit features 6 co-located conferences and 3 dinner short courses. Multiple registration options are available. Download the digital brochure for all details.

2017 Program Highlights

The 2017 Clinical Trial Innovation Summit program focuses on key issues and opportunities in the clinical trial industry, including patient recruitment, site selection, data integration, existing data sources, mobile tech, project management, outsourcing, vendor management, budgeting and contracting, quality (QbD) in trial conduct, risk-based monitoring and clinical auditing.

  • ICH E6 guidance, including gap analysis, action plans, and project plans from clinical trial quality and risk management expert Andy Lawton
  • An assessment of current and future trial technologies: social media, search engine optimization, targeted digital advertising, artificial intelligence and virtual reality
  • Real examples of big data analytics in clinical trials from Takeda, Bayer, Janssen, and BMS
  • Proven strategies for determining timelines, key activity needs, and effective communication for clinical trial outsourcing
  • Case studies from AbbVie, Merck, and Samumed on new methods of risk mitigation, issue management, and oversight plans to ensure quality clinical trials
  • How to navigate regulation and data quality and quantity challenges of wearables, sensors and mHealth from pharma teams in the trenches
  • Lessons learned from AstraZeneca, BMS, Gilead, and several others at the frontline of RBM roll-out

Join us in Boston

Would you like to know how we can help with your company’s data challenges, using our clinical business intelligence software ta-Scan and our other data solutions? Then feel free to pop by at Booth #3 in the exhibition hall (Essex North / Center Ballroom) or make an appointment with MDCPartners Chief Scientific Officer David Cocker or Director of Business Development, North America Matt Tumasz. They will gladly show you our state of the art software tools.

Register Today

Use our discount code MDPCTL for $200 off your registration cost.*

How to Register:
Online: https://chidb.com/reg/ctl/reg.asp
By telephone: +1 781-972-5400

We hope to see you in Boston!

* Our clients and colleagues will receive $200 off for commercial attendees or $100 off for academic, government and hospital-affiliated attendees. You must mention priority keycode MDPCTL to receive the registration discount. Alumni, Twitter, LinkedIn, Facebook or any other promotional discounts cannot be combined. Discounts not applicable on event short courses. This discount does not apply to previously registered attendees.

Join the ta-Scan Team at SCOPE 2016!

February 23-25, 2016 | Miami

SCOPE 2016 Summit for Clinical Operations Executives

The year hasn’t ended yet, but we are already looking forward to new events in 2016: in February, MDCPartners’ ta-Scan team will be present in Miami at SCOPE 2016, the annual Summit for Clinical Operations Executives. Click here to view the meeting program.

Learn more about advanced feasibility modelling from CSO David Cocker’s presentation:

“Advanced Feasibility Modelling”
Tuesday, February 23, 3:20 – 3:35 PM
Track: Global Site Selection, Feasibility Assessment and Site Management

Presentation abstract: From unrealistic protocols to delinquent sites, feasibility catches the rap as the leading contributing factor for missed timelines and budget overruns. Feasibility basically is a confidence prediction of your downstream research network. But what if internal data is inadequate to provide a reliable assessment? Patient recruitment simulation software is plugging many information gaps in the feasibility departments. This presentation highlights new data sources, algorithms and visualizations to shore up your feasibility assessments.

Speaker bio: David Cocker is an experienced healthcare executive with a deep understanding of global clinical operations. Graduated as a biomedical engineer, he has been in the central clinical laboratory business for 25 years founding some of Europe’s largest clinical labs. As MDCPartners’ CSO, David now works with data scientists and project managers to develop information technologies to help pharmaceutical companies discover valuable insights from public data.

You can also meet us personally at booths # 506 & 508 to see a live demonstration of our ta-Scan software. Just drop by or make an appointment with Matt Tumasz or David Cocker.

If ta-Scan is new for you, you can learn about its concepts in this short, informative ta-Scan video.

ta-Scan Infomercial

Learn more about the concepts of our ta-Scan software in this video highlighting pharmaceutical industry data deficiencies and ta-Scan’s solutions.

David Cocker’s keynote on Data-Driven Decision-Making in Immunotherapy in Washington

7-8 October 2015 | Ronald Reagan Building and International Trade Center, Washington DC

MDCPartners and the ta-Scan clinical business intelligence team are pleased to announce a keynote presentation by David Cocker on the third Big Data in Clinical Development conference in Washington.

Join us on Wednesday 7 October at 9:30 AM, when David Cocker will give a keynote presentation on Data-Driven Decision-Making in Immunotherapy.

Also meet Matt and David in the exhibition hall (booth # 11) to get the latest updates on ta-Scan, or contact us to make an appointment.

Click here to see the complete meeting agenda.

Phacilitate Big Data Banner

Check out our new MDCPartners website!

Welcome to the restyled MDCPartners website!

After several years of faithful service, we thought it was time to retire the old site and replace it with a more “to-the-point” website in a modern skin.

From the MDCPartners website, you can navigate easier to the product websites for ta-Scan and normScan.
We have also included pages on new technologies for ta-Scan data visualization and custom-made data solutions, to underline our commitment to exploring better ways to visualize public data, and also to announce projects on including pharmaceutical clients’ in-house data in the typical MDCPartners context.
Our Jobs page is getting busy too. Feel free to spread the profiles to potential candidates.

We hope you like the fresh new look of the website and the improved navigation. Contact us for feedback or suggestions.

— the MDCPartners team

MDCPartners FLTR Mireille Bart David Piet

MDCPartners to attend 51st Annual DIA Meeting

Join MDCPartners’ Clinical Business Intelligence Team as they represent ta-Scan at the 51st Annual DIA Meeting

June 15-17, 2015 | Washington DC, United States

MDCPartners will be attending the 51st Annual DIA Meeting in Washington from the 15th to the 17th of June 2015. This meeting brings together professionals from all areas within the biopharmaceutical and life sciences industry to cover all aspects and viewpoints, allowing for true networking with colleagues.

ta-Scan’s clinical business intelligence team will be presenting their newly launched Research Landscape Comparison (RLC) Wizard. To meet with MDCPartners’ business representatives David Cocker or Matt Tumasz in Washington, feel free to get in touch or come by and say hello at booth 2449!

Click here to see the final DIA meeting program.

DIA 2015 banner

Categories

 

Tags

 

Connect with MDCPartners

Follow us on LinkedIn

Follow us on Twitter

Top of Page